1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 20 to 80 Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-J081-202, NCT00946153
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-702, NCT01133977
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-G000-201, NCT00784303
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-G000-204, NCT01111461
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-A001-102, NCT00121680
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-E044-101, NCT00121719
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 20 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-J081-103, NCT00280397
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 20 to 74 Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-J081-110, NCT00832819
|
|
9.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 to 45 Sponsor: Pharmaceutical / Industry Protocol IDs: E7080-J081-105, NCT01268293
|